title: N-(4-Meth-oxy-phen-yl)-N'-(5-nitro-1,3-thia-zol-2-yl)urea.
abstract: The title compound, C(11)H(10)N(4)O(4)S, is a derivative of N-(4-meth-oxy-benz-yl)-N'-(5-nitro-1,3-thia-zol-2-yl)urea (AR-A014418), a known glycogen synthase kinase 3β (GSK-3β) inhibitor. All non-H atoms in the mol-ecule are essentially coplanar, with an r.m.s. deviation of 0.045 Å and a maximum deviation of 0.115 (2) Å for the carbonyl O atom. In the crystal structure, mol-ecules are linked via N-H⋯O hydrogen bonds into one-dimensional chains along [101].
authors: Alan J
authors: AJ
authors: Lough
authors: Justin W
authors: JW
authors: Hicks
authors: John F
authors: JF
authors: Valliant
authors: Alan A
authors: AA
authors: Wilson
authors: Neil
authors: N
authors: Vasdev
references: Bioorg Med Chem Lett. 2005 Dec 1;15(23):5270-3
references: 16202587
references: Acta Crystallogr D Biol Crystallogr. 2009 Feb;65(Pt 2):148-55
references: 19171970
references: Acta Crystallogr A. 1995 Jan 1;51 ( Pt 1):33-8
references: 7702794
references: J Biol Chem. 2003 Nov 14;278(46):45937-45
references: 12928438
references: Acta Crystallogr A. 2008 Jan;64(Pt 1):112-22
references: 18156677